BioPharma Dive9h
Merck opens $1B vaccine plant in North Carolina
Unveiling of the new factory comes as Merck and other pharma companies face pressure to reshore manufacturing back to the U.S.
New Version of Merck’s Blockbuster Cancer Drug Threatened by Patent Battle
The company has asked the U.S. patent office to reconsider patents that could prevent it from selling an update to Keytruda.
Merck Injects $1 Billion To Expand Vaccine Production In US
Merck unveils a $1 billion vaccine manufacturing facility in Durham, North Carolina, expanding its U.S. production and ...
Shareholders that lost money on Merck & Co., Inc.(MRK) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
NEW YORK, NY / ACCESS Newswire / March 10, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn ...
Merck & Co.'s Real Value: A Deep Dive Into Its Fundamentals
While Merck reported strong financial results in recent quarters, it faces both upsides and risks in the future. Read why I'm ...
Yahoo Finance4d
Merck & Co., Inc. (MRK)
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other most undervalued high quality stocks to buy according to analysts. Is a Market Rally Around ...
Just The News4d
Merck virologist recalls becoming whistleblower over maker's blockbuster MMR measles, mumps vaccine
Stephen Krahling was a published cancer researcher when vaccine maker Merck brought him on board as a virologist in 1999. That’s when he says he found himself embroiled in an all-hands-on-deck ...